Login
Subscribe
Opinion: In Defense of Preprints
Opinion: In Defense of Preprints
In response to two November 2021 articles in The Scientist that called out preprints as a source of medical misinformation, the cofounders of bioRxiv and medRxiv say it’s not the publishing model that’s at fault.
In response to two November 2021 articles in The Scientist that called out preprints as a source of medical misinformation, the cofounders of bioRxiv and medRxiv say it’s not the publishing model that’s at fault.
science communication, careers, science publishing
Report: Diversity Strengthens Publications
Tracy Vence | Feb 25, 2014 | 1 min read
US scientists are more likely to coauthor papers with researchers of similar ethnicity to themselves, but manuscripts with a more diverse list of authors have greater impact, a study shows.